| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Neuropathology,*
Faculty of
Medicine, University of Tokyo, Tokyo; the Department of Forensic
Medicine,
Kyoto Prefectural University of
Medicine, Kyoto; the Department of Neurology,
Tokyo Women's Medical College, Tokyo; Athena Neurosciences
Inc.,§
South San Francisco, California; the
Department of Pathology,¶
Gunma Cancer Center,
Ohta, Japan; Gunma University School of Health
Sciences,**
Maebashi, Japan; and Core Research
for Evolutional Science and Technology,||
Japan Science
and Technology Corporation, Kawaguchi, Japan
We previously noted that some aged human cortical specimens containing very low or negligible levels of amyloid ß-protein (Aß) by enzyme immunoassay (EIA) provided prominent signals at 6~8 kd on the Western blot, probably representing sodium dodecyl sulfate (SDS)-stable Aß dimer. Re-examination of the specificity of the EIA revealed that BAN50- and BNT77-based EIA, most commonly used for the quantitation of Aß, capture SDS-dissociable Aß but not SDS-stable Aß dimer. Thus, all cortical specimens in which the levels of Aß were below the detection limits of EIA were subjected to Western blot analysis. A fraction of such specimens contained SDS-stable dimer at 6~8 kd, but not SDS-dissociable Aß monomer at ~4 kd, as judged from the blot. This Aß dimer is unlikely to be generated after death, because (i) specimens with very short postmortem delay contained the Aß dimer, and (ii) until 12 hours postmortem, such SDS-stable Aß dimer is detected only faintly in PDAPP transgenic mice. The presence of Aß dimer in the cortex may characterize the accumulation of Aß in the human brain, which takes much longer than that in PDAPP transgenic mice.
This article has been cited by other articles:
![]() |
W. Farris, S. G. Schutz, J. R. Cirrito, G. M. Shankar, X. Sun, A. George, M. A. Leissring, D. M. Walsh, W. Q. Qiu, D. M. Holtzman, et al. Loss of Neprilysin Function Promotes Amyloid Plaque Formation and Causes Cerebral Amyloid Angiopathy Am. J. Pathol., July 1, 2007; 171(1): 241 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Huang, A. Mouri, H. Kokubo, R. Nakajima, T. Suemoto, M. Higuchi, M. Staufenbiel, Y. Noda, H. Yamaguchi, T. Nabeshima, et al. Neprilysin-sensitive Synapse-associated Amyloid-beta Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function J. Biol. Chem., June 30, 2006; 281(26): 17941 - 17951. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Vanderstichele, G. De Meyer, N. Andreasen, V. Kostanjevecki, A. Wallin, A. Olsson, K. Blennow, and E. Vanmechelen Amino-Truncated {beta}-Amyloid42 Peptides in Cerebrospinal Fluid and Prediction of Progression of Mild Cognitive Impairment Clin. Chem., September 1, 2005; 51(9): 1650 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Urbanc, L. Cruz, F. Ding, D. Sammond, S. Khare, S. V. Buldyrev, H. E. Stanley, and N. V. Dokholyan Molecular Dynamics Simulation of Amyloid {beta} Dimer Formation Biophys. J., October 1, 2004; 87(4): 2310 - 2321. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawarabayashi, M. Shoji, L. H. Younkin, L. Wen-Lang, D. W. Dickson, T. Murakami, E. Matsubara, K. Abe, K. H. Ashe, and S. G. Younkin Dimeric Amyloid {beta} Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's Disease J. Neurosci., April 14, 2004; 24(15): 3801 - 3809. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schmechel, H. Zentgraf, S. Scheuermann, G. Fritz, R. Pipkorn, J. Reed, K. Beyreuther, T. A. Bayer, and G. Multhaup Alzheimer {beta}-Amyloid Homodimers Facilitate A{beta} Fibrillization and the Generation of Conformational Antibodies J. Biol. Chem., September 12, 2003; 278(37): 35317 - 35324. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawarabayashi, L. H. Younkin, T. C. Saido, M. Shoji, K. H. Ashe, and S. G. Younkin Age-Dependent Changes in Brain, CSF, and Plasma Amyloid {beta} Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease J. Neurosci., January 15, 2001; 21(2): 372 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morishima-Kawashima, N. Oshima, H. Ogata, H. Yamaguchi, M. Yoshimura, S. Sugihara, and Y. Ihara Effect of Apolipoprotein E Allele {{epsilon}}4 on the Initial Phase of Amyloid {beta}-Protein Accumulation in the Human Brain Am. J. Pathol., December 1, 2000; 157(6): 2093 - 2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Funato, M. Enya, M. Yoshimura, M. Morishima-Kawashima, and Y. Ihara Presence of Sodium Dodecyl Sulfate-Stable Amyloid {beta}-Protein Dimers in the Hippocampus CA1 Not Exhibiting Neurofibrillary Tangle Formation Am. J. Pathol., July 1, 1999; 155(1): 23 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamazaki, T.-Y. Chang, C. Haass, and Y. Ihara Accumulation and Aggregation of Amyloid beta -Protein in Late Endosomes of Niemann-Pick Type C Cells J. Biol. Chem., February 2, 2001; 276(6): 4454 - 4460. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Scheuermann, B. Hambsch, L. Hesse, J. Stumm, C. Schmidt, D. Beher, T. A. Bayer, K. Beyreuther, and G. Multhaup Homodimerization of Amyloid Precursor Protein and Its Implication in the Amyloidogenic Pathway of Alzheimer's Disease J. Biol. Chem., August 31, 2001; 276(36): 33923 - 33929. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |